I'm Ivan Kairatov, and I've spent my career at the intersection of biotechnology and oncology, focusing on how we can use innovative tools to outsmart cancer. For too long in breast cancer care, we’ve been playing a waiting game. A patient undergoes successful treatment, and we tell them they are
In a world where traditional drug discovery can take over a decade with a success rate hovering in the single digits, RNA-based therapeutics are emerging as a revolutionary force. With the integration of artificial intelligence, this field is not just advancing; it's experiencing a quantum leap. To
The next breakthrough in cardiovascular medicine might not originate from a high-tech laboratory or a sprawling clinical trial, but from the silent, detailed images captured by an MRI machine. A revolutionary approach using artificial intelligence is now deciphering the complex visual data within
The painstaking and often inefficient process of manually sifting through thousands of patient records to find eligible candidates for clinical trials has long been a major bottleneck in medical innovation. The use of Artificial Intelligence in patient screening represents a significant advancement
In the intricate world of medical imaging, the human eye, despite its remarkable capabilities and years of training, is not infallible, and a single, overlooked shadow on a brain scan can have profound consequences for a patient's diagnosis and treatment path. The immense pressure on radiologists
For decades, the diagnosis of Alzheimer’s disease has been a process of exclusion, often coming too late, after irreversible damage has been done. But the ground is shifting beneath our feet. With the advent of simple blood tests, we are entering a new era of proactive neurological health. To help
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58